Abstract:Background: Diabetic foot ulcers (DFUs) pose a significant risk for individuals with long-standing diabetes mellitus, leading to hospitalizations and potential amputations. The prevalence of diabetes in India is expected to reach 57 million by 2025. DFUs are resolvable complications, with proper treatment resulting in healing rates of 75–80%, while a percentage of cases may require amputations. Effective management requires a multidisciplinary approach, including sterile dressing, meticulous foot care, and appropriate antibiotic therapy. The irrational use of antibiotics, often based on random choices before obtaining culture reports, contributes to the burden. DFUs impact the quality of life, exacerbate the economic burden, and affect low socioeconomic groups disproportionately. This study proposes an antibiotic policy to reduce irrational antibiotic use until sample reports are available, promoting more rational prescribing practices. Aim and Objectives: The aim of the study was (i) to identify commonly infecting organisms in DFU cases; (ii) to look for the prevalence of antimicrobial resistance in cases of DFU; and (iii) to come up with a disease and region-specific antibiogram. Materials and Methods: The culture and sensitivity reports of DFU swabs were retrospectively procured from multiple microbiology labs between September 2018 and September 2019. The data collected were tabulated into Excel worksheet and analyzed. The results were then simplified into pie and bar charts. Many descriptive statistical tools such as percentage and mean were used to come to a conclusion. Results: 159 cases of DFUs were examined, revealing that 81% of cases occurred in men and the incidence increased with age, with 65% of cases being over the age of 50 years. Staphylococcus aureus was the most common infecting organism (20.75%), followed by Klebsiella, Escherichia coli, and Pseudomonas. Non-healing ulcers in 9.7% of cases showed no bacterial growth. Amikacin exhibited the highest sensitivity (60%), whereas ceftazidime demonstrated the highest resistance (66%). Over 80% of patients had long-standing diabetes for over 15 years. Conclusion: The study highlights the prevalence of antibiotic-resistant organisms and the need for a well-defined antibiotic protocol. Uncontrolled diabetes increases the risk of DFUs. Empirical antibiotic treatment is crucial before culture reports, and amikacin, cefazolin, and vancomycin combination therapy is effective. Ceftazidime, amoxicillin/clavulunate, and cefotaxime should be avoided. The patient education on foot care is vital.

Potential risk factors and outcomes of infection with multidrug resistance among diabetic patients having ulcers: 7 years study

Prevalence and interrelationships of foot ulcer, risk-factors and antibiotic resistance in foot ulcers in diabetic populations: A systematic review and meta-analysis

Risk Factors for Multidrug-Resistant Bacterial Infection in Diabetic Foot Ulcers

The diabetic foot infections: Biofilms and antimicrobial resistance

Insight into multidrug-resistant microorganisms from microbial infected diabetic foot ulcers

Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: A prospective study

Antibiotic Resistance Profiles of Extended-Spectrum β-Lactamase (ESBL)- and Metallo-β-Lactamase (MBL)-Producing Klebsiella pneumoniae Isolates From Diabetic Foot Ulcers: Implications for Treatment Strategies

Microbial Profile and Antimicrobial Susceptibility Pattern in Diabetic Foot Ulcer Patients Attending a Tertiary Care Hospital

Prevalence of multidrug‐resistant bacterial infections in diabetic foot ulcers: A meta‐analysis

Bacteriological profile and antibiotic sensitivity pattern in diabetic foot ulcer: A retrospective study

Microbial spectrum, antibiotic susceptibility profile, and biofilm formation of diabetic foot infections (2014–18): a retrospective multicenter analysis

Distribution of multidrug-resistant bacterial infections in diabetic foot ulcers and risk factors for drug resistance: a retrospective analysis

Diabetic foot ulcer in India: Aetiological trends and bacterial diversity

MDR Isolates Virulence of DNase activity Identified Staphylococcus and Pseudomonas Species from Diabetic Foot Ulcer

Identification of biofilm-producing microorganism’s and drug susceptibility pattern from diabetic foot ulcer patients at Puducherry

Clinical and bacteriological profile of diabetic foot infections in a tertiary care

Prevalence and Antibiotic Resistance of Klebsiella pneumoniae in Diabetic Foot Ulcer

Common pathogens associated with infected diabetic foot ulcers: A retrospective cohort study in a specialized medical center in Jeddah, Saudi Arabia

Prospective Observational Study of Microbiology of Infected Diabetic Foot Ulcers in a Tertiary-Care Hospital

Resistance to Some New Drugs and Prevalence of ESBL- and MBL-Producing Enterobacteriaceae Uropathogens Isolated from Diabetic Patients

Aerobic bacteria isolated from diabetic foot ulcers of Egyptian patients: types, antibiotic susceptibility pattern and risk factors associated with multidrug-resistant organisms